SEER-Medicare data show just 4% of older adults with blood cancers enter clinical trials, revealing disparities and fixable ...

Re:Cognition Health, a global leader in brain and memory health research, and Cera – Europe’s largest digital‑first home healthcare provider – have announced a new collaboration designed to expand ...

Panelist and director of the leukemia program at Massachusetts General Hospital, Amir Fathi, MD, explained that catchment ...

Long-term VBC success hinges on robust data integrity and seamless integration across clinical, claims, government and personal health data sources.

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (“Theralase®” or the “Company”), a clinical stage pharmaceutical company dedicated ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

In order to move forward, it is expected that existing data from the Phase 2b/3 Anavex 2-73 AD-004 program be submitted to the FDA. In December, as expected, the CHMP adopted a negative opinion on the ...

Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral ...

The program invites health systems and clinical groups to validate an on-premises AI refinery that eliminates manual data-cleaning overhead and recovers lost revenue. MEMPHIS, TENNESSEE / ACCESS Newsw ...

Q1 2026 earnings call: blarcamesine Alzheimer’s FDA/EMA timeline, ACCESS-AD partnership, and $131.7M cash runway—read now.

Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...

Real-world and clinical trial data underscore long-term safety and effectiveness in pediatric and adult NPC patients ...